FDA issued a Warning Letter to RX South DBA RX3 Compounding Pharmacy LLC on 10/23/2014 for a previous inspection.
483 RX South DBA RX3 Compounding Pharmacy Apr 2016

483 RX South DBA RX3 Compounding Pharmacy Apr 2016

Haijing Hu FDA, Linda Murphy FDA, Stacie Woods FDA$119.00 - Available Now

FDA investigators audited the RX South DBA RX3 Compounding Pharmacy - Chester, VA, United States facility and issued 6 inspectional observations (via FDA 483) on 18 Apr 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 6
  • Inspection end: 18 Apr 2016
  • Location: Chester, United States
  • FEI: 3008723337
Add To Cart